IRTC

iRhythm Technologies Inc

IRTC, USA

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

https://www.irhythmtech.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
IRTC
stock
IRTC

Cim Investment Management Inc. Sells 5,929 Shares of iRhythm Technologies $IRTC MarketBeat

Read more →
IRTC
stock
IRTC

Eventide Asset Management LLC Has $106.48 Million Stock Holdings in iRhythm Technologies $IRTC MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$219.9333

Analyst Picks

Strong Buy

9

Buy

3

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

45.12

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-4.28 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.52 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Medium

10.40 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

7.16

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 110.73% of the total shares of iRhythm Technologies Inc

1.

Vanguard Group Inc

(10.0712%)

since

2025/06/30

2.

Sands Capital Management, LLC

(9.0748%)

since

2025/06/30

3.

BlackRock Inc

(8.5584%)

since

2025/06/30

4.

Artisan Partners Limited Partnership

(8.5311%)

since

2025/06/30

5.

Sands Capital Global Growth Equity

(8.2495%)

since

2025/06/30

6.

Capital Research Global Investors

(4.6902%)

since

2025/06/30

7.

Vanguard Total Stock Mkt Idx Inv

(3.1323%)

since

2025/07/31

8.

State Street Corp

(2.7033%)

since

2025/06/30

9.

American Funds SMALLCAP World A

(2.4704%)

since

2025/06/30

10.

Vanguard Small Cap Index

(2.411%)

since

2025/07/31

11.

iShares Russell 2000 ETF

(2.3967%)

since

2025/08/31

12.

Geode Capital Management, LLC

(2.3884%)

since

2025/06/30

13.

Blair William & Co

(2.3012%)

since

2025/06/30

14.

BNP Paribas Investment Partners SA

(2.2866%)

since

2025/06/30

15.

Mackenzie Investments

(2.2716%)

since

2025/06/30

16.

Eventide Asset Management, LLC

(2.1526%)

since

2025/06/30

17.

Champlain Investment Partners, LLC

(2.0581%)

since

2025/06/30

18.

American Funds New Economy A

(1.946%)

since

2025/06/30

19.

Capital Group New Economy Comp

(1.946%)

since

2025/06/30

20.

Artisan U.S. Mid-Cap Growth

(1.9403%)

since

2025/06/30

21.

Artisan Mid Cap Investor

(1.9403%)

since

2025/06/30

22.

UBS Asset Mgmt Americas Inc

(1.8914%)

since

2025/06/30

23.

Fuller & Thaler Asset Management Inc

(1.8255%)

since

2025/06/30

24.

Bessemer Group Inc

(1.7717%)

since

2025/06/30

25.

JPMorgan Chase & Co

(1.753%)

since

2025/06/30

26.

Stephens Inv Mgmt Group LLC

(1.721%)

since

2025/06/30

27.

Canada Life US Small-Mid Cap Growth F

(1.7171%)

since

2025/06/30

28.

Eventide Gilead N

(1.445%)

since

2025/06/30

29.

Sands Capital Global Growth A USD Acc

(1.4306%)

since

2025/07/31

30.

Vanguard Small Cap Growth Index Inv

(1.3565%)

since

2025/07/31

31.

Bridge Builder Small/Mid Cap Growth

(1.3534%)

since

2025/08/31

32.

Allspring Global Investments Holdings, LLC

(1.3519%)

since

2025/06/30

33.

FMR Inc

(1.3079%)

since

2025/06/30

34.

Stephens SMID Select Growth

(1.2432%)

since

2025/06/30

35.

Wellington Management Company LLP

(1.2304%)

since

2025/06/30

36.

FullerThaler Behavioral Small-Cap Growth

(1.2182%)

since

2025/06/30

37.

Old Westbury Large Cap Strategies

(1.2126%)

since

2025/04/30

38.

FullerThaler Behavioral Sm-Cp Gr R6

(1.175%)

since

2025/07/31

39.

Champlain Small Company Fund, LLC

(1.1033%)

since

2025/08/31

40.

Vanguard Explorer Inv

(1.1013%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.012

Latest Release

Date

2025-09-30

EPS Actual

0.06

EPS Estimate

-0.32

EPS Difference

0.38

Surprise Percent

118.75%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(3.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.